HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Niharika Chauhan Selected Research

CX-2029

1/2022Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody-Drug Conjugate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Niharika Chauhan Research Topics

Disease

1Neoplasms (Cancer)
01/2022

Drug/Important Bio-Agent (IBA)

1CX-2029IBA
01/2022
1monomethyl auristatin EIBA
01/2022
1AntigensIBA
01/2022
1CitrullineIBA
01/2022
1Valine (L-Valine)FDA Link
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022

Therapy/Procedure

1Therapeutics
01/2022